|
DNAJC27 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.01149999995631E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.61747999999351E-05 |
| Normal-vs-Stage2 |
7.402000E-02 |
| Normal-vs-Stage3 |
3.168800E-04 |
| Normal-vs-Stage4 |
7.417700E-04 |
| Stage1-vs-Stage2 |
1.318410E-01 |
| Stage1-vs-Stage3 |
3.324000E-01 |
| Stage1-vs-Stage4 |
2.102400E-01 |
| Stage2-vs-Stage3 |
8.510300E-02 |
| Stage2-vs-Stage4 |
4.374100E-02 |
| Stage3-vs-Stage4 |
6.281000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.0162999999962E-05 |
| Normal-vs-AfricanAmerican |
7.224000E-04 |
| Normal-vs-Asian |
5.099400E-03 |
| Caucasian-vs-AfricanAmerican |
4.566800E-01 |
| Caucasian-vs-Asian |
2.482000E-01 |
| AfricanAmerican-vs-Asian |
1.367570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.09530000017111E-07 |
| Normal-vs-Female |
1.071750E-02 |
| Male-vs-Female |
2.500400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.5397899999936E-05 |
| Normal-vs-Extreme_Weight |
1.81600000004334E-06 |
| Normal-vs-Obese |
2.303800E-03 |
| Normal-vs-Extreme_Obese |
3.918400E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.131200E-01 |
| Normal_Weight-vs-Obese |
9.124300E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.037200E-01 |
| Extreme_Weight-vs-Obese |
8.742500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.871000E-01 |
| Obese-vs-Extreme_Obese |
8.459000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.920300E-03 |
| Normal-vs-Age(41-60Yrs) |
1.883040E-03 |
| Normal-vs-Age(61-80Yrs) |
3.69839999958543E-07 |
| Normal-vs-Age(81-100Yrs) |
1.303960E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.131000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.064800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.028600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.888300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.631970E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.399200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.44130000000609E-05 |
| Normal-VS-Type2 PRCC |
9.15160003334137E-09 |
| Normal-VS-KIRP CIMP |
3.236000E-03 |
| Normal-VS-Unclassified PRCC |
5.518000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.023600E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.340400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.331600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.759600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.802370E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.069000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.71949999963716E-07 |
| Normal-vs-N1 |
2.799700E-04 |
| Normal-vs-N2 |
4.208400E-02 |
| N0-vs-N1 |
3.843800E-01 |
| N0-vs-N2 |
8.452600E-01 |
| N1-vs-N2 |
8.415800E-01 |
|
|
